| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rezolute, Inc. | CFO | Common Shares | 238K | $688K | $2.89 | Mar 26, 2025 | Direct |
| Rezolute, Inc. | CFO | Common Shares | 40K | $202K | $5.04 | Mar 26, 2025 | Held by PoC Capital LLC |
| Rezolute, Inc. | CFO | Common Shares | 20K | $101K | $5.04 | Mar 26, 2025 | Held by spouse |
| Rezolute, Inc. | CFO | Common Shares | 23K | $66.2K | $2.88 | Mar 26, 2025 | Minor child #1 |
| Rezolute, Inc. | CFO | Common Shares | 4.5K | $22.7K | $5.04 | Mar 26, 2025 | Held by minor child #2 |
| Rezolute, Inc. | CFO | Common Shares | 4.5K | $22.7K | $5.04 | Mar 26, 2025 | Held by minor child #3 |
| NEPHROS INC | CEO Specialty Renal Products | Common Stock | 8.95K | $19.7K | $2.20 | May 27, 2021 | By UTMA #1 |
| NEPHROS INC | CEO Specialty Renal Products | Common Stock | 8.67K | $19.1K | $2.20 | May 27, 2021 | By UTMA #2 |
| Rezolute, Inc. | CFO | Employee Stock Option (Right to Buy) | 45K | Feb 16, 2025 | Direct | ||
| NEPHROS INC | CEO Specialty Renal Products | Stock Option (Right to Buy) | 20K | May 24, 2021 | Direct | ||
| NEPHROS INC | CEO Specialty Renal Products | Common Stock Warrants (Right to Buy) | 0 | May 24, 2021 | By UTMA #1 | ||
| NEPHROS INC | CEO Specialty Renal Products | Common Stock Warrants (Right to Buy) | 0 | May 24, 2021 | By UTMA #2 |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RZLT | Rezolute, Inc. | Mar 26, 2025 | 2 | $57.7K | 4 | Mar 28, 2025 | CFO |
| RZLT | Rezolute, Inc. | Feb 16, 2025 | 2 | $0 | 4 | Feb 19, 2025 | CFO |
| RZLT | Rezolute, Inc. | Dec 18, 2024 | 1 | $42.9K | 4 | Dec 18, 2024 | CFO |
| RZLT | Rezolute, Inc. | Dec 12, 2024 | 1 | $41.4K | 4 | Dec 12, 2024 | CFO |
| RZLT | Rezolute, Inc. | Dec 9, 2024 | 1 | $53.2K | 4 | Dec 10, 2024 | CFO |
| RZLT | Rezolute, Inc. | Sep 23, 2024 | 1 | $0 | 4 | Sep 24, 2024 | CFO |
| RZLT | Rezolute, Inc. | Jun 14, 2024 | 1 | $162K | 4 | Jun 14, 2024 | CFO |
| RZLT | Rezolute, Inc. | May 29, 2024 | 1 | $1.58K | 4 | May 31, 2024 | CFO |
| RZLT | Rezolute, Inc. | May 23, 2024 | 2 | $9.67K | 4 | May 28, 2024 | CFO |
| RZLT | Rezolute, Inc. | Mar 15, 2024 | 1 | $33.8K | 4 | Mar 19, 2024 | CFO |
| RZLT | Rezolute, Inc. | Mar 8, 2024 | 1 | $96.3K | 4 | Mar 8, 2024 | CFO |
| RZLT | Rezolute, Inc. | Feb 16, 2024 | 3 | $66.7K | 4 | Feb 20, 2024 | CFO |
| RZLT | Rezolute, Inc. | Jan 23, 2024 | 1 | $0 | 4 | Jan 25, 2024 | CFO |
| RZLT | Rezolute, Inc. | Jan 22, 2024 | 0 | $0 | 3 | Jan 25, 2024 | CFO |
| NEPH | NEPHROS INC | May 24, 2021 | 2 | -$1.88K | 4/A | Jun 1, 2021 | CEO Specialty Renal Products |